精优药业(00858.HK)盈警:预计中期录得亏损4.5亿至4.8亿港元
Core Viewpoint - Jingyou Pharmaceutical (00858.HK) anticipates a loss between HKD 450 million and HKD 480 million for the six months ending September 30, 2025, contrasting with a profit recorded in the same period of 2024 [1] Financial Performance - The expected loss is primarily attributed to unrealized losses on the fair value of the company's convertible bond investments, whereas the same project recorded fair value gains in the corresponding period of 2024 [1] - The unrealized loss is characterized as non-cash in nature [1] Operational Stability - The company's operational performance remains stable during the current period [1]